Real-world retrospective observational study exploring the effectiveness and safety of antifibrotics in idiopathic pulmonary fibrosis

BACKGROUND: Pirfenidone and nintedanib are the only disease-modifying treatments available for idiopathic pulmonary fibrosis (IPF). Our aim was to test their effectiveness and safety in clinical practice. METHODS: This is a single-centre retrospective observational study undertaken at a specialised...

Descripción completa

Detalles Bibliográficos
Autores principales: Wright, William Alexander, Crowley, Louise E, Parekh, Dhruv, Crawshaw, Anjali, Dosanjh, Davinder P, Nightingale, Peter, Thickett, David R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Interstitial Lung Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006845/
https://www.ncbi.nlm.nih.gov/pubmed/33771813
http://dx.doi.org/10.1136/bmjresp-2020-000782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006845/
https://www.ncbi.nlm.nih.gov/pubmed/33771813
http://dx.doi.org/10.1136/bmjresp-2020-000782

Ejemplares similares